Willkie head of litigation Tariq Mundiya discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.
A pension fund’s complaint targeting two activist investors who settled with discount retailer Big Lots last year could have far-reaching implications for insurgent fund campaigns at companies in the state and beyond.
Vyacheslav Fos, a professor in Boston College's finance department, discussed his new paper on shareholder record dates and findings that corporations can disclose such dates in ways that leave retail investors and some sophisticated shareholders in the dark.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.